Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Le Chevalier

Showing results (161-170 of 223) with videos related to

Pageof 23
Sort By:
Cancer|September 1, 1995
Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques)B Dautzenberg, C Chastang, R Arriagada, et al.
Journal of the National Cancer Institute|January 1, 1992
Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinomaT Le Chevalier, R Arriagada, M Tarayre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomasA Le Cesne, E Antoine, M Spielmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaT Le Chevalier, R Arriagada, E Quoix, et al.
Cancer Research|December 1, 1989
Identification and measurement of calcitonin precursors in serum of patients with malignant diseasesP P Ghillani, P Motté, F Troalen, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
Journal of the National Cancer Institute|March 20, 1991
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patientsT Le Chevalier, R Arriagada, E Quoix, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Pageof 23

Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Cancer|September 1, 1995
Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques)B Dautzenberg, C Chastang, R Arriagada, et al.
Journal of the National Cancer Institute|January 1, 1992
Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinomaT Le Chevalier, R Arriagada, M Tarayre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomasA Le Cesne, E Antoine, M Spielmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinomaT Le Chevalier, R Arriagada, E Quoix, et al.
Cancer Research|December 1, 1989
Identification and measurement of calcitonin precursors in serum of patients with malignant diseasesP P Ghillani, P Motté, F Troalen, et al.
Cancer|March 20, 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinomaK Fizazi, I Cojean, J P Pignon, et al.
Journal of the National Cancer Institute|March 20, 1991
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patientsT Le Chevalier, R Arriagada, E Quoix, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patientsF Boue, Z Pastran, M Spielmann, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Pageof 23